These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 26097589)
1. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma. Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589 [TBL] [Abstract][Full Text] [Related]
2. CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. Lv ZD; Kong B; Liu XP; Dong Q; Niu HT; Wang YH; Li FN; Wang HB Int J Clin Exp Pathol; 2014; 7(10):6671-8. PubMed ID: 25400746 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis. Zhang S; Wang Y; Dai SD; Wang EH BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of GLTSCR2 expression is correlated with breast cancer progression. Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033 [TBL] [Abstract][Full Text] [Related]
5. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer. Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369 [TBL] [Abstract][Full Text] [Related]
6. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer. Ramos FS; Serino LT; Carvalho CM; Lima RS; Urban CA; Cavalli IJ; Ribeiro EM Genet Mol Res; 2015 Jun; 14(2):6960-7. PubMed ID: 26125904 [TBL] [Abstract][Full Text] [Related]
7. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue. Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of NKD1 in human osteosarcoma and its clinical significance. Chen X; Xu P; Zhu J; Liu F Mol Med Rep; 2018 Jan; 17(1):1111-1117. PubMed ID: 29115501 [TBL] [Abstract][Full Text] [Related]
9. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Oka K; Suzuki T; Onodera Y; Miki Y; Takagi K; Nagasaki S; Akahira J; Ishida T; Watanabe M; Hirakawa H; Ohuchi N; Sasano H Int J Cancer; 2011 Apr; 128(8):1770-82. PubMed ID: 20533549 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab. Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689 [TBL] [Abstract][Full Text] [Related]
11. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast. Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969 [TBL] [Abstract][Full Text] [Related]
12. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome. La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269 [TBL] [Abstract][Full Text] [Related]
13. Expression of XB130 in human ductal breast cancer. Li J; Sun W; Wei H; Wang X; Li H; Yi Z Int J Clin Exp Pathol; 2015; 8(5):5300-8. PubMed ID: 26191231 [TBL] [Abstract][Full Text] [Related]
14. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo. Yang Q; Ji G; Li J Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760 [TBL] [Abstract][Full Text] [Related]
15. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458 [TBL] [Abstract][Full Text] [Related]
16. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099 [TBL] [Abstract][Full Text] [Related]
17. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype. Chung YR; Kim H; Park SY; Park IA; Jang JJ; Choe JY; Jung YY; Im SA; Moon HG; Lee KH; Suh KJ; Kim TY; Noh DY; Han W; Ryu HS Hum Pathol; 2015 Jul; 46(7):1027-35. PubMed ID: 26004371 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer: Role of IGF-1 and IGFBP-3 expression in prognostication. Raval A; Trivedi S Indian J Exp Biol; 2016 Oct; 54(10):619-629. PubMed ID: 30084561 [TBL] [Abstract][Full Text] [Related]
19. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
20. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer. Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]